Q2 EPS Forecast for Summit Therapeutics Reduced by Analyst
Summit Therapeutics Inc. (NASDAQ:SMMT – Free Report) – Investment analysts at HC Wainwright cut their Q2 2025 earnings estimates for shares of Summit Therapeutics in a research report issued on Monday, April 28th. HC Wainwright analyst M. Kapoor now anticipates that the company will post earnings of ($0.10) per share for the quarter, down from […]
Summit Therapeutics Inc. (NASDAQ:SMMT – Free Report) – Investment analysts at HC Wainwright cut their Q2 2025 earnings estimates for shares of Summit Therapeutics in a research report issued on Monday, April 28th. HC Wainwright analyst M. Kapoor now anticipates that the company will post earnings of ($0.10) per share for the quarter, down from […]
